Loading stock data…
PROCEPT BioRobotics Corporation (PRCT)
$17.38-0.32 (-1.81%)
Market OpenUpdated 3:06 PM EDT
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
PROCEPT BioRobotics Corporation in the Healthcare sector is trading at $17.38 with a market capitalization of $1.5B. Wall Street consensus targets $29.30 (10 analysts), implying a +68.6% move over the next 12 months. The stock is currently near its 52-week low of $17.17, remaining 38.0% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +68.6% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 24) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $83.13M↑ | $76.38M↓ | $83.33M↑ | $79.18M↑ | $69.16M |
| Gross Profit | $53.95M↑ | $46.31M↓ | $54.01M↑ | $51.75M↑ | $44.16M |
| Operating Income | -$32.61M↓ | -$31.04M↓ | -$23.19M↓ | -$22.19M↑ | -$27.44M |
| Net Income | -$31.64M↓ | -$29.84M↓ | -$21.41M↓ | -$19.58M↑ | -$24.74M |
Peer Comparison
JNJUNHPFE
Fundamentals
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic syste...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.50B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.83
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-29.47%
Volume
Today's trading volume
675,436
Recent News
Evercore Initiates PROCEPT BioRobotics (PRCT) At “Outperform,” Cites Aquablation Growth Potential
With significant hedge fund interest and strong upside, PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the most promising robotics stocks. PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is building a clinical case for Aquablation that could redefine its addressable market, with two major prostate cancer study milestones drawing fresh analyst attention to the stock. On May 28, 2026, […]
Here is Why PROCEPT BioRobotics (PRCT) is Amongst the Best Robotics and Automation Names Right Now
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the 10 best robotics and automation stocks to invest in. On May 28, PROCEPT BioRobotics Corp. (NASDAQ:PRCT) disclosed two significant accomplishments in its WATER IV prostate cancer clinical program. Firstly, the company received FDA approval for an Investigational Device Exemption for the second randomized study to evaluate Aquablation […]
BlackBerry, Take-Two initiations among today's top calls on Wall Street
BlackBerry, Take-Two initiations among today's top calls on Wall Street
Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?
Is PRCT a good stock to buy? We came across a bullish thesis on PROCEPT BioRobotics Corporation on r/ValueInvesting by mrmrmrj. In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT BioRobotics Corporation’s share was trading at $20.91 as of June 17th. Procept BioRobotics (PRCT) is a high-growth surgical robotics company with rapid revenue scaling […]
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls